A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line

BMC Urology

Volumn 13, Issue , 2013, Pages

  Zhu, Yong Tong ^a   Lei, Cheng Yong ^a   Luo, Yang ^a   Liu, Na ^b   He, Cheng Wu ^a   Chen, Wei ^a   Li, Fei ^a   Deng, Yong Jian ^a   Tan, Wan Long ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Cancer stem cells; Chemotherapy; MB49 cell line; Proliferation

Indexed keywords

AGAR; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD44V ANTIGEN; CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; MITOMYCIN; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; TRANSCRIPTION FACTOR NANOG; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BLADDER CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; FLUORESCENCE ACTIVATED CELL SORTING; IN VIVO STUDY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; SERUM FREE CULTURE MEDIUM; STEM CELL; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SEPARATION; CULTURE MEDIA, SERUM-FREE; FLOW CYTOMETRY; MICE; NEOPLASTIC STEM CELLS; URINARY BLADDER NEOPLASMS;

EID: 84886740931     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-13-57     Document Type: Article

References (27)

1. Novel immunotherapy for metastatic bladder cancer using vaccine of human interleukin-2 surface-modified MB 49 cells. Zhang X, Shi X, Li J, Hu Z, Guo F, Huang X, Zhang Z, Sun P, Jing Y, Gao J, Tan W, Urology 2011 78 3 721 722
2. A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer. Zhang X, Shi X, Li J, Hu Z, Zhou D, Gao J, Tan W, J Urol 2012 187 3 1071 1079 10.1016/j.juro.2011.10.126 22266013
3. Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer. Shi X, Zhang X, Li J, Guo F, Hu Z, Jing Y, Bai L, Chen S, Wan P, Wang F, Gao J, Tan W, Urol Oncol 2013 31 6 883 893 10.1016/j.urolonc.2011.08.001 21924648
4. Normal and neoplastic urothelial stem cells: getting to the root of the problem. Ho PL, Kurtova A, Chan KS, Nat Rev Urol 2012 9 10 583 594 10.1038/nrurol.2012.142 22890301
5. CD133(+) single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential. Li G, Liu C, Yuan J, Xiao X, Tang N, Hao J, Wang H, Bian X, Deng Y, Ding Y, Clin Exp Metastasis 2010 27 7 517 527 10.1007/s10585-010-9341-0 20617370
6. Chemotherapy sorting can be used to identify cancer stem cell populations. Li L, Li B, Shao J, Wang X, Mol Biol Rep 2012 39 11 9955 9963 10.1007/s11033-012-1864-9 22744428
7. Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer. Zhang Y, Wang Z, Yu J, Shi J, Wang C, Fu W, Chen Z, Yang J, Cancer Lett 2012 322 1 70 77 10.1016/j.canlet.2012.02.010 22343321
8. Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples. Bentivegna A, Conconi D, Panzeri E, Sala E, Bovo G, Vigano P, Brunelli S, Bossi M, Tredici G, Strada G, Dalpra L, Cancer Sci 2010 101 2 416 424 10.1111/j.1349-7006.2009. 01414.x 19961489
9. Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Jung S, Panchalingam KM, Rosenberg L, Behie LA, Stem Cells Int 2012 2012 123030 22645619
10. Establishment of human ovarian serous carcinomas cell lines in serum free media. Pan Z, Hooley J, Smith DH, Young P, Roberts PE, Mather JP, Methods 2012 56 3 432 439 10.1016/j.ymeth.2012.03.003 22445873
11. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Yao CL, Chu IM, Hsieh TB, Hwang SM, Exp Hematol 2004 32 8 720 727 10.1016/j.exphem.2004.05.021 15308323
12. Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF, Mol Cell Biochem 2012 363 1-2 257 268 22160925
13. HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Liao WT, Jiang D, Yuan J, Cui YM, Shi XW, Chen CM, Bian XW, Deng YJ, Ding YQ, Clin Cancer Res 2011 17 11 3569 3578 10.1158/1078-0432.CCR-10-2533 21474578
14. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, Qi Q, Lu N, Tao L, Wang XT, You QD, Guo QL, Cancer Lett 2009 279 1 13 21 10.1016/j.canlet.2009.01.016 19232461
15. Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis. Varghese S, Whipple R, Martin SS, Alexander HR, PLoS One 2012 7 12 52825 10.1371/journal.pone.0052825 23285196
16. Identification of side population cells from bladder cancer cells by DyeCycle Violet staining. She JJ, Zhang PG, Wang ZM, Gan WM, Che XM, Cancer Biol Ther 2008 7 10 1663 1668 10.4161/cbt.7.10.6637 18787416
17. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Yanamoto S, Kawasaki G, Yamada S, Yoshitomi I, Kawano T, Yonezawa H, Rokutanda S, Naruse T, Umeda M, Oral Oncol 2011 47 9 855 860 10.1016/j.oraloncology.2011.06.501 21757396
18. Current strategies for identification of glioma stem cells: adequate or unsatisfactory? Brescia P, Richichi C, Pelicci G, J Oncol 2012 2012 376894 22685459
19. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Han ME, Jeon TY, Hwang SH, Lee YS, Kim HJ, Shim HE, Yoon S, Baek SY, Kim BS, Kang CD, Oh SO, Cell Mol Life Sci 2011 68 21 3589 3605 10.1007/s00018-011-0672-z 21448722
20. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. Felthaus O, Ettl T, Gosau M, Driemel O, Brockhoff G, Reck A, Zeitler K, Hautmann M, Reichert TE, Schmalz G, Morsczeck C, Biochem Biophys Res Commun 2011 407 1 28 33 10.1016/j.bbrc.2011.02.084 21342656
21. Implication of expression of Nanog in prostate cancer cells and their stem cells. Gong C, Liao H, Guo F, Qin L, Qi J, J Huazhong Univ Sci Technolog Med Sci 2012 32 2 242 246 10.1007/s11596-012-0043-5 22528228
22. Cancer stem cells: models and concepts. Dalerba P, Cho RW, Clarke MF, Annu Rev Med 2007 58 267 284 10.1146/annurev.med.58.062105.204854 17002552
23. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Visvader JE, Lindeman GJ, Nat Rev Cancer 2008 8 10 755 768 10.1038/nrc2499 18784658
24. Characterization of a stem cell population in lung cancer A549 cells. Sung JM, Cho HJ, Yi H, Lee CH, Kim HS, Kim DK, Abd EA, Kim JS, Landowski CP, Hediger MA, Shin HC, Biochem Biophys Res Commun 2008 371 1 163 167 10.1016/j.bbrc.2008.04.038 18423378
25. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, Masuyama K, Oral Oncol 2009 45 7 633 639 10.1016/j. oraloncology.2008.10.003 19027347
26. Therapeutic implications of cancer initiating cells. Scopelliti A, Cammareri P, Catalano V, Saladino V, Todaro M, Stassi G, Expert Opin Biol Ther 2009 9 8 1005 1016 10.1517/14712590903066687 19545218
27. The biology of cancer stem cells. Lobo NA, Shimono Y, Qian D, Clarke MF, Annu Rev Cell Dev Biol 2007 23 675 699 10.1146/annurev.cellbio.22.010305.104154 17645413